Biotech · Private company
Sun Pharma Advanced Research Company Limited
Track this companyFree. Adds Sun Pharma Advanced Research Company Limited to your Dealase workspace and tells you when its record changes.
Clinical trials232 recruiting or active
Pipeline programs36From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline36
- Brimonidine Tartrate Ophthalmic SolutionPhase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Brimonidine Tartrate Ophthalmic SuspensionPhase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Reference0912Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Reference1507Phase 3 · Advanced Biliary Tract CancerClinicalTrials.gov · fetched Nov 12, 2026
- SDN-037Phase 3 · Inflammation and Pain Associated With Ocular SurgeryClinicalTrials.gov · fetched Nov 12, 2026
- SPARC0912Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- SPARC0913Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- SPARC0921Phase 3 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- SPARC1104 modified dose regimen IPhase 3 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- SPARC1104 modified dose regimen IIPhase 3 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- SPARC1104 modified dose regimen IIIPhase 3 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- SPARC1507Phase 3 · Advanced Biliary Tract CancerClinicalTrials.gov · fetched Nov 12, 2026
- K0706Phase 2 · Early Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SPARC1103 high dosePhase 2 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- SPARC1103 low dosePhase 2 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- Vodobatinib (K0706) capsulesPhase 2 · Healthy (For Part A)ClinicalTrials.gov · fetched Nov 12, 2026
- DL2Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- DL3Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- DL4Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- DL5Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Dose level (DL)1Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- K0706Phase 1 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- K0706Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Part 1Phase 1 · HER2-negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Part 2Phase 1 · HER2-negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Part 3Phase 1 · HER2-negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Reference001 type IPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Reference001 type IIPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- SCO-120Phase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- SPARC001 type IPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- SPARC001 type IIPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- SPARC1023 IPhase 1 · Solid Tumor in Advanced StageClinicalTrials.gov · fetched Nov 12, 2026
- SPARC1023 IIPhase 1 · Solid Tumor in Advanced StageClinicalTrials.gov · fetched Nov 12, 2026
- SPARC1028Phase 1 · Solid Tumor in Advanced StageClinicalTrials.gov · fetched Nov 12, 2026
- K0706CML, RelapsedClinicalTrials.gov · fetched Nov 12, 2026
- SezabyNeonatal SeizureClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials23
- Study of Electrocardiogram (ECG) Safety of Sezaby in Neonatal SeizuresPHASE4 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07923734 · fetched Nov 12, 2026
- A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.PHASE1 · RECRUITING · started Aug 12, 2025ClinicalTrials.gov NCT07042100 · fetched Nov 12, 2026
- A Study in Patients With Advanced Breast CancerPHASE1 · TERMINATED · started May 20, 2022ClinicalTrials.gov NCT04942054 · fetched Nov 12, 2026
- Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female SubjectsPHASE1 · COMPLETED · started Mar 4, 2020ClinicalTrials.gov NCT04242953 · fetched Nov 12, 2026
- K0706 for Patients Diagnosed With Dementia With Lewy BodiesPHASE2 · TERMINATED · started Sep 5, 2019ClinicalTrials.gov NCT03996460 · fetched Nov 12, 2026
- PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706PHASE2 · TERMINATED · started Feb 18, 2019ClinicalTrials.gov NCT03655236 · fetched Nov 12, 2026
- A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507PHASE3 · WITHDRAWN · started Dec 1, 2018ClinicalTrials.gov NCT02597465 · fetched Nov 12, 2026
- Evaluation of Efficacy and Safety of SDN-037PHASE3 · COMPLETED · started Sep 28, 2018ClinicalTrials.gov NCT03426267 · fetched Nov 12, 2026
- Evaluation of Safety and Efficacy of PDP-716PHASE3 · COMPLETED · started Sep 13, 2018ClinicalTrials.gov NCT03450629 · fetched Nov 12, 2026
- To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy VolunteersPHASE1 · COMPLETED · started Apr 15, 2018ClinicalTrials.gov NCT03445338 · fetched Nov 12, 2026
- Bioavailability Study of K0706 in Healthy SubjectsPHASE1 · COMPLETED · started Oct 28, 2017ClinicalTrials.gov NCT03316820 · fetched Nov 12, 2026
- Safety and Tolerability Study of K0706 in Subjects With Parkinson's DiseasePHASE1 · COMPLETED · started Mar 30, 2017ClinicalTrials.gov NCT02970019 · fetched Nov 12, 2026
- Bioavailability Study of SPARC001 (Study 2) in Healthy Adult VolunteersPHASE1 · COMPLETED · started Feb 6, 2017ClinicalTrials.gov NCT02991261 · fetched Nov 12, 2026
- Bioavailability Study of SPARC001(Study 1) in Healthy Adult VolunteersPHASE1 · COMPLETED · started Jan 15, 2017ClinicalTrials.gov NCT02991222 · fetched Nov 12, 2026
- Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML TherapiesPHASE1_PHASE2 · TERMINATED · started Jun 27, 2016ClinicalTrials.gov NCT02629692 · fetched Nov 12, 2026
- Study of SPARC1103 in Subjects With SpasticityPHASE2 · COMPLETED · started Apr 21, 2014ClinicalTrials.gov NCT02027025 · fetched Nov 12, 2026
- Safety Study of SPARC1104PHASE3 · COMPLETED · started Apr 9, 2013ClinicalTrials.gov NCT01797185 · fetched Nov 12, 2026
- Efficacy and Safety of SPARC0921 in Subjects With SpasticityPHASE3 · COMPLETED · started Nov 14, 2012ClinicalTrials.gov NCT01457352 · fetched Nov 12, 2026
- Pharmacokinetic, Safety and Tolerability Study of SPARC1028PHASE1 · COMPLETED · started May 1, 2012ClinicalTrials.gov NCT01305512 · fetched Nov 12, 2026
- Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin CombinationPHASE1 · COMPLETED · started Oct 1, 2011ClinicalTrials.gov NCT01304303 · fetched Nov 12, 2026
- Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular HypertensionPHASE3 · COMPLETED · started Nov 1, 2010ClinicalTrials.gov NCT00945958 · fetched Nov 12, 2026
- Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular HypertensionPHASE3 · COMPLETED · started Jul 1, 2010ClinicalTrials.gov NCT00947661 · fetched Nov 12, 2026
- Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous TreatmentsTEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT07517315 · fetched Nov 12, 2026